Modulation Effect of tACS on Chronic Low Back Pain

Recruiting Phase 2 Interventional Study
Chronic Low-back Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Basic Science
Participants needed
80 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Investigating the modulation effect of tACS

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Volunteers 18-60 years of age 2. Meet the Classification Criteria of the chronic LBP (having low back pain for more than 6 months) 3. At least 4/10 clinical pain on the 0-10 LBP NRS 4. At least a 10th grade English-reading level; English can be a second language provided that…
Contacts

JIAN KONG

6179620978

jkong2@mgh.harvard.edu

CONTACT